CMI Communications

CMI Communications is active on: #Bluesky 🦋, where the ID/clinical microbio community is growing fast (@cmicomms.bsky.social / #IDSky) LinkedIn Instagram Thank you for your support! 🙏 #IDtwitter #IDXposts #OpenAccess

CMI Comms will no longer be posting on X. We hope to see you on #Bluesky 🦋, where the ID/clinical microbio community is growing fast (@cmicomms.bsky.social / #IDSky), or on LinkedIn or Instagram. Thank you for your support! 🙏 #IDtwitter #IDXposts #OpenAccess

Though we all expected it, here is some of the first population-level evidence that post-pandemic antibiotic use bounced back fast to pre-pandemic levels (🙏Catherine @PlussSuard et al / 🙏reviewers). #IDtwitter #IDXposts #OpenAccess @ABsteward @ESCMID sciencedirect.com/science/articl…

One week until these ID A-listers take the stage at the 2024 SIDP Annual Meeting! 🌴 💊 🦠 Swipe for full meeting schedule. Virtual registration still available! Hear from Drs. @MikeMndudley @dianapark703 @lacymycin @mattdavis138 @amylcarr @priyanori & Ryan Tomlin #IDWeek2024

Past ESCMID President Annelies Zinkernagel gives her views on how our society has grown and evolved since the world of infectious diseases was thrust into the spotlight following the COVID-19 pandemic. #ESCMID #COVID-19 #InfectiousDiseases

@GermHunterMD @ESCMID Thank you! (Audience, not base.) Maybe for proofs they'll do repeating headers for rushed readers. ;-) We are a bit protective of ESCMID & its good work... And though the authors didn't contact us, they're right that a big part of Communicable's audience is US-based. :-)

Good compilation, thanks. But #Communicable is not a US-based podcast. It's @ESCMID's, so... #idxposts #idtwitter

★ Just published: #Communicable podcast episode - The Nightmare Series, part 2: How to deal with carbapenemase producers. Angela @ThomasTangden @KanjSouha & David Paterson @davidantibiotic discuss these nightmare organisms Listen: share.transistor.fm/s/4a3afe04 #IDtwitter #IDxposts

On Monday we are releasing a new #Communicable podcast episode - the 2nd round of the Nightmare Series. Angela & @ThomasTangden sit down w/ David Patterson & @KanjSouha to discuss clinical challenges of dealing w/ carbapenemase producers. Swipe for preview! #IDtwitter #IDxposts

In 630 patients w/ cardiac implantable e-device & #bacteraemia, E. coli most common (26%) but caused 0 #CIED infections; S. aureus less common (21%) but caused 63% of CIED infections Read full article: sciencedirect.com/science/articl… #IDtwitter #IDxposts @essiryodi

RT @SIDPharm: SIDP is thrilled to announce the launch of our new Breakpoints – The SIDP Podcast website! The Breakpoints website is your 1…

Dr @danyeoh & colleagues on CT imaging of invasive mold infections in immunocompromised children: nodules & halo sign most common but no one feature predicts causative pathogen ➡️ microbiological sampling remains essential sciencedirect.com/science/articl… @ABsteward #IDtwitter #IDxposts

★ Just published: #Communicable podcast episode “Pipeline update: #newantibiotics & other #antimicrobials that you might actually use” @ErinMcCreary, Markus Zeitlinger (@EMA_News) & @MikeMndudley (@Qpexbio) unpack what's to come! share.transistor.fm/s/1e15821f #IDTwitter #idxposts

We are so excited for our next #Communicable episode on #newantibiotics dropping in 2 days, we're sharing another teaser! You can find all of our episodes on your favorite podcast platform (Spotify, Apple, Youtube, etc) & on our #CMIComms homepage escmid.org/guidelines-jou…

RT @accpinfdprn: Calling all #IDPRN and @SIDPharm members!! Are you or a team member presenting at #IDWeek2024 or #ACCPAM24? Please comple…

RT @Contagion_Live: In our latest Bench to Bedside column from @SIDPharm @JRBPharmD and @vivianytsai discuss using long-acting lipoglycope…

RT @DrEmilyMcD: Calling all #IDTwitter peeps! Please help us by filling out this thought provoking survey on diagnosis and management of CD…

Our next #Communicable episode on pipeline #antibiotics is dropping Monday. Swipe for a preview of what’s in store for you! @ErinMcCreary @MikeMndudley @Qpexbio @EMA_News @ESCMID #IDtwitter #IDxposts #CMIComunications #OpenAccess